Are Wall Street Analysts Bullish on Cooper Companies Stock?

Cooper Companies, Inc. (COO), a San Ramon, California-based company that develops, manufactures, and markets contact lenses, has a market capitalization of $14.9 billion. The company operates in two segments, CooperVision and CooperSurgical, and offers spherical, toric, and multifocal contact lenses to address vision challenges like astigmatism, presbyopia, and myopia.

Despite lagging behind the broader market in the past year, with a growth of 1.6% compared to the S&P 500 Index's 20.5% surge, COO's stock has fallen by nearly 6.7% in 2026, underperforming the S&P 500's 12.1% gain.

Analysts are not optimistic about COO's stock due to the company's performance. Over the past two years, COO's annual sales growth has been nearly 6.5%, which is below the industry average for healthcare companies. Moreover, analysts estimate that COO's sales growth will be 4.2% for the next year, indicating weak demand. Furthermore, COO's returns on capital are below average, suggesting that the management lacks compelling investment opportunities.

For the current fiscal year, which ends in October, analysts anticipate that COO's earnings per share (EPS) will rise by 12.4% to $4.63 on a diluted basis. The company has exceeded the consensus estimate in each of the last four quarters. Among the 18 analysts who cover COO stock, the consensus is a "Moderate Buy," based on nine "Strong Buy" ratings, one "Moderate Buy," seven "Holds," and one "Strong Sell." This rating has remained relatively consistent over the past months.

As of August 14, Citi analyst Joanne Wuensch maintained a "Hold" rating for COO and set a price target of $80. With a mean price target of $80.88, COO's stock has an upside of 6.1% compared to its current market price. The Street-high target of $103 implies a robust 35.1% upside from the current level.